ReproCELL Incorporated (TYO:4978)

ReproCELL Revenue

ReproCELL had revenue of 546.00M JPY in the quarter ending June 30, 2026, with 14.95% growth. This brings the company's total for the last twelve months to 2.30B, down -18.70% year-over-year. In the fiscal year ending March 31, 2026, ReproCELL had annual revenue of 2.23B, down -25.02%. That makes ReproCELL the 35,519th largest company in the world by revenue and 3,622nd in Japan.

• Revenue (ttm): 2.30B
• Revenue Growth: -18.70%
• P/S Ratio: 5.50
• Revenue / Employee: 22.81M
• Employees: 101
• Market Cap: 12.98B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Research Support Business 1.95B 87.4%
• Medical Business 281.04M 12.6%

By Geography

Chart

• United States 1.19B 53.2%
• Japan 517.61M 23.2%
• Europe 443.23M 19.8%
• Others 83.33M 3.7%

Fiscal year ended Mar 31, 2026 See the full ReproCELL breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.23B	-745.00M	-25.02%
Mar 31, 2025	2.98B	552.00M	22.75%
Mar 31, 2024	2.43B	-527.00M	-17.85%
Mar 31, 2023	2.95B	719.00M	32.18%
Mar 31, 2022	2.23B	948.00M	73.72%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 24, 2026

Data Sources Report a data error